Veto-pharma

What Veto-pharma does

Véto-pharma is a French pharmaceutical laboratory founded in 1982 and headquartered in Palaiseau, France, specialising in animal health with a dedicated concentration on honey bee health through its Bee Science division. The company develops, manufactures, and commercialises veterinary pharmaceutical products targeting the principal threats to honey bee colonies, including amitraz-based varroa mite treatments (Apivar, Apivar 2.0, Amiflex, Amiflex 2.0), oxalic acid formulations (Api-Bioxal, Oxybee), natural and rotational options (ApiLife Var, Bayvarol), Asian hornet traps (VespaCatch Original, VespaCatch Select), nutritional supplements (MegaBee), live probiotics (Bactobee), and a 3-in-1 varroa infestation monitoring tool (Varroa EasyCheck). Its core technology rests on a proprietary controlled-release strip-manufacturing process that achieves uniform active-ingredient distribution throughout Apivar strips and on six years of R&D behind the Amiflex flash treatment, with claims of 97%+ efficacy in field studies. The company operates a 400-hive experimental apiary and a Bee Science R&D team dedicated to bee health for over 25 years.

The business operates two complementary arms. The branded-products arm generates revenue through B2B distribution via beekeeping supply wholesalers such as BeeMaid, Dancing Bee Equipment (Canada) and Mann Lake (USA), serving both professional/commercial and hobbyist beekeepers across France, broader Europe, the USA, Canada, Australia, and New Zealand, with products supporting over 6 million colonies annually. The second arm, Véto-pharma Manufacturing, functions as a contract development and manufacturing organisation (CDMO) offering bespoke development, manufacturing, and packaging of non-sterile veterinary products for external or oral use to other veterinary-sector companies. Go-to-market combines a product-led growth motion with extensive scientific content marketing (webinars, downloadable guides, scientific posters, Kahoot quizzes, blog, newsletter) and a multilingual regional website presence (France, Europe, North America, Spain). Pricing is not publicly disclosed; Amiflex in some markets requires a Certified Applicator License to purchase, creating a regulatory gating mechanism.

Name

Veto-pharma

Legal name

VETO PHARMA

Website

https://veto-pharma.com

Company type

Private

Founded year

1982

Operating status

Operating

Short description

French pharmaceutical laboratory founded in 1982 that develops and manufactures animal health products focused on honey bee health, including varroa mite treatments, Asian hornet traps, probiotics, and a CDMO contract manufacturing service for non-sterile veterinary products, serving beekeepers and veterinary companies across Europe, North America, and Oceania.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Bee Health Management & Treatments (Mite/Disease Control Products & Services) (AFAEAHAK)

Keywords

• Animal health products
• Varroa mite treatments
• Bee health solutions
• Veterinary pharmaceuticals
• Honey bee nutrition

Headquarters

HQ city

Palaiseau

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Bee Health Products: Véto-pharma develops, produces, and commercializes a range of veterinary pharmaceutical products for bee health including varroa treatments (Apivar, Apivar 2.0, Amiflex, Api-Bioxal, Oxybee), Asian hornet traps (VespaCatch Original, VespaCatch Select), bee nutrition products (MegaBee), monitoring tools (Varroa EasyCheck), and probiotics (Bactobee). Revenue is generated through product sales to beekeepers via distribution networks.
2. CDMO Manufacturing Services: Véto-pharma Manufacturing operates as a Contract Development and Manufacturing Organization (CDMO), offering bespoke development, manufacturing, and packaging of non-sterile veterinary products for external or oral use to other companies in the veterinary sector. This is a B2B service revenue stream.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Veto-pharma develops, manufactures, and commercializes veterinary pharmaceutical products focused on honey bee health, including amitraz-based varroa mite treatments (Apivar, Apivar 2.0, Amiflex), oxalic acid treatments (Api-Bioxal Poudre, Oxybee), Asian hornet traps (VespaCatch Original/Select), standardized varroa monitoring tools (Varroa EasyCheck), bee nutrition products (Bactobee probiotics, MegaBee protein supplement), and rotation treatments (ApiLife Var, Bayvarol). The company also operates a CDMO arm offering contract development, manufacturing, and packaging of non-sterile veterinary pharmaceutical products for external or oral use to other veterinary sector companies.

Product overview

Veto-pharma is a French pharmaceutical laboratory founded in 1982, specializing in animal health with a particular focus on honey bee health. The company operates two main divisions: Veto-pharma Bee Science develops and commercializes pharmaceutical products and solutions for beekeeping, including varroa mite treatments (Apivar, Apivar 2.0, Amiflex/Amiflex 2.0, ApiLife Var, Bayvarol, Api-Bioxal, Oxybee), monitoring tools (Varroa EasyCheck), Asian hornet traps (VespaCatch Original and Select), bee nutrition products (MegaBee, Bactobee), and conducts bee health research. Veto-pharma Manufacturing operates as a CDMO partner providing contract development and manufacturing services for non-sterile veterinary pharmaceutical products. The company supports over 6 million bee colonies annually and has dedicated R&D facilities including an experimental apiary with 400 hives.

Differentiator

Problem solved

Functional benefit

Brands

• Véto-pharma Bee Science: Research and development department dedicated to bee health for over 25 years, supporting the beekeeping sector with innovative solutions
• Véto-pharma Manufacturing

Products and services

• Apivar Amitraz-based varroa mite treatment in strip form, manufactured using a proprietary controlled-release process that ensures even distribution of the active ingredient throughout the strip. Works by contact as bees pick up the molecule from the strip surface, delivering 97%+ efficacy in studies conducted 2018-2021. Sold to professional and hobbyist beekeepers via beekeeping supply distributors.
• Apivar 2.0 Next-generation amitraz-based varroa treatment strips designed to deliver faster action, greater convenience, and extended protection for honey bee colonies, with improved efficacy achieved at a lower amitraz dose versus the original Apivar. Targeted at professional and hobbyist beekeepers.
• Amiflex / Amiflex 2.0 Amitraz-based 7-day 'flash' treatment for varroa mites, providing rapid action without temperature constraints during use and allowing legal, safe application between or after honey flows. Amiflex 2.0 is a fully accessible, license-free version for the US market, while the original Amiflex requires a Certified Applicator License in some regions.
• ApiLife Var Natural treatment against varroa mites, intended for inclusion in rotation-based integrated pest management strategies for beekeepers.
• Bayvarol Varroa mite treatment designed for rotation use as part of an integrated pest management (IPM) strategy alongside other treatments such as Apivar and ApiLife Var.
• Api-Bioxal Poudre Varroa treatment based on oxalic acid in powder form with a new sugar-free formula. Provides strong efficacy against phoretic varroa mites and can be applied by sublimation or by dripping. Available in France as of 2025.
• Oxybee Oxalic acid-based treatment for varroa mites, intended for use in rotation-based integrated pest management programs.
• Bactobee Powdered complementary bee feed containing live bacteria (Pediococcus acidilactici) that helps reduce the effects of pesticide exposure and environmental stressors, promoting gut health, colony resilience, and immunity. Available in Canada and New Zealand.
• MegaBee High-quality protein supplement for honey bees designed to support queen quality, speed up package bee production, and reduce colony losses.
• Varroa EasyCheck First ready-to-use 3-in-1 varroa infestation monitoring tool supporting alcohol wash, sugar roll, and CO2 injection methods. A standardized monitoring method showing 82.3% efficiency in field studies, significantly higher than home-made methods (64.9-65.2%).
• VespaCatch Original Natural trap for capturing Asian hornets (Vespa velutina / yellow-legged hornet), designed to maximize catches of the hornet species and protect honey bee colonies.
• VespaCatch Select Selective and adaptive trap for Asian hornets featuring adjustable entry sizes and a second filtering cone that enhances trapping effectiveness while preserving non-target insects. Targets the Asian hornet (Vespa velutina) to protect honey bee colonies.
• Veto-pharma Manufacturing (CDMO Services) Contract Development and Manufacturing Organization (CDMO) service offering bespoke development, manufacturing, and packaging of non-sterile veterinary pharmaceutical products for external or oral use, delivered through the company's Palaiseau, France pharmaceutical manufacturing site. Serves veterinary sector companies as a B2B partner.

Quantifiable outcome

• Products support over 6 million bee colonies annually
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Canadian Honey CouncilcoreStrategic or Co-development PartnerThe Canadian Honey Council collaborated with Véto-pharma and the Canadian Bee Tech Transfer Programs to organize an exclusive beekeeping webinar series on Varroa destructor management. The collaboration included presentations from bee tech transfer programs across Canada and panel discussions on Canadian bee health management.
• Dr. Gérald ThervillecoreStrategic or Co-development PartnerDr. Gérald Therville, a French veterinarian with a specialized diploma in Beekeeping, co-authored Véto-pharma's 20-page Integrated Varroa Mite Management throughout the Seasons guide, bringing clinical veterinary expertise to the educational content.
• Pajuelo ConsultoresminorStrategic or Co-development PartnerPajuelo Consultores, beekeeping experts, co-authored Véto-pharma's 28-page Nutrition Guide for Honey Bees, contributing specialized knowledge on bee nutrition optimization.
• BeeMaidcoreChannel Partner/ Reseller/ DistributorBeeMaid is the authorized Canadian distributor for Apivar 2.0 and Amiflex products, making Véto-pharma's varroa treatments available to Canadian beekeepers.
• Dancing Bee EquipmentcoreChannel Partner/ Reseller/ DistributorDancing Bee Equipment is an authorized Canadian distributor for Apivar 2.0 and Amiflex varroa treatments, expanding access to Véto-pharma's products in the Canadian market.
• Canadian Bee Tech Transfer ProgramscoreStrategic or Co-development PartnerAtlantic, Manitoba, and Saskatchewan Bee Tech Transfer Programs participated in the Canadian Honey Council webinar series on Varroa management organized with Véto-pharma support, providing regional perspectives on treatment strategies.
• Phil LesterminorStrategic or Co-development PartnerPhil Lester (New Zealand) delivered a talk on 'Integrated resistance management for acaricide use on Varroa destructor' as part of the Canadian Honey Council webinar series, contributing scientific expertise on varroa resistance.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Betterbee: US-based beekeeping supply retailer and distributor serving hobbyist and sideliner beekeepers. Comparable as a regional channel touching the same US customer base that Véto-pharma addresses through its distributor network.
• Dadant & Sons: Long-established US beekeeping supply manufacturer and distributor offering equipment, medications, and feed. Overlaps with Véto-pharma at the US beekeeper customer level through its product catalogue and distribution footprint.
• Mann Lake: Major US-based beekeeping supply manufacturer and distributor. Functions as a channel partner for Véto-pharma (distributing Amiflex and other products) and as a regional player in the same bee-health category.

Broad incumbents

• Ceva Santé Animale: Large French-headquartered animal-health pharmaceutical company with activities across multiple species and categories, including bee health. Comparable as a French animal-health pharma incumbent with overlapping veterinary CDMO-style manufacturing capabilities.
• Vétoquinol: French-headquartered animal-health pharmaceutical company with a portfolio spanning multiple species. Comparable as a French veterinary pharma incumbent with manufacturing capabilities and CDMO-adjacent services.
• Boehringer Ingelheim Animal Health: Global animal-health division of Boehringer Ingelheim with a broad vaccine and pharmaceutical portfolio and large-scale veterinary manufacturing. Relevant comparator for scale, regulatory expertise, and CDMO operations across species.
• Virbac: Global French-origin animal-health pharmaceutical company producing pharmaceuticals across companion and production animals. Comparable as a broad veterinary pharmaceutical player with CDMO and formulation capabilities at greater scale.

Direct peers

• Vita Bee Health: A UK-based bee-health company selling varroa treatments (notably the fluvalinate-based Apistan) and other beekeeping products. Direct overlap with Véto-pharma's core varroa-treatment franchise and target customer base of professional and hobbyist beekeepers.
• NOD Apiary Products: US-based producer of varroa treatments including Api-Bioxal (oxalic acid), a chemistry also offered by Véto-pharma in its Api-Bioxal range. Competes head-on in the North American varroa-control market served by Véto-pharma's distributors.

Emerging players

• ApiHex / Api-Arista / Equivalent oxalic-acid product makers: Smaller bee-health firms and generic oxalic-acid treatment producers (e.g., Api-Bioxal-style generic producers) operating in adjacent European and North American markets. They compete with Véto-pharma's oxalic-acid-based treatments and increasingly the next-generation flash offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/veto-pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veto-pharma